Cleared Traditional

K080274 - AMBULO 2400

K080274 is an FDA 510(k) clearance for AMBULO 2400, manufactured by Tiba Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 82-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2008
Decision
82d
Days
Class 2
Risk

K080274 is an FDA 510(k) clearance for the AMBULO 2400. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Tiba Medical, Inc. (Portland, US). The FDA issued a Cleared decision on April 23, 2008 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Tiba Medical, Inc. devices

FDA 510(k) Submission Details - K080274

510(k) Number K080274 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2008
Decision Date April 23, 2008
Days to Decision 82 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 125d · This submission: 82d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 902
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K080274.
YA HORNG ARM TYPE DIGITAL BLOOD PRESSURE MONITOR, MODELS BP-600, BP-600R, BP-600U, BP-600B, BP-600RB, BP-600UB, BP-600J
K081590 · Ya Horng Electronic Co., Ltd. · Jun 2008
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, MODEL BP3MQ1-2D
K080337 · Microlife Corp. · May 2008
WRIST BLOOD PRESSURE MONITOR, MODEL WS-1100/WS-1100PV
K080177 · Nihon Seimitsu Sokki Co., Ltd. · May 2008
BLOOD PRESSURE MONITOR, MODELS BP-102, BP-103, BP-201 AND BP-202
K080789 · Sejoy Electronics & Instruments Co., Ltd. · Apr 2008
CLEVER TD-3026 DIGITAL WRIST BLOOD PRESSURE MONITOR, MODEL TD-3026
K073445 · Taidoc Technology Corporation · Apr 2008
1500 PRO
K080289 · Omron Healthcare, Inc. · Feb 2008